NBE-Therapeutics AG
Verified IntelAt NBE Therapeutics we strive to develop best-in-class oncology treatments to increase survival and improve quality of life for cancer patients worldwide. Through our highly innovative novel in-house developed technologies, we have created a next generation antibody drug conjugate platform targeting solid tumors. Our platform allows us to develop targeted medicines, that through a long-lasting immune oncology effect, could reduce or even eradicate tumors. Our dedicated international team has been able to create a pipeline of ADC product candidates in various stages of development to enter clinical phases to create better treatments for cancer patients in need of more selective drugs.
At NBE Therapeutics we strive to develop best-in-class oncology treatments to increase survival and improve quality of life for cancer patients worldwide. Through our highly innovative novel in-house developed technologies, we have created a next generation antibody drug conjugate platform targeting solid tumors. Our platform allows us to develop targeted medicines, that through a long-lasting immune oncology effect, could reduce or even eradicate tumors. Our dedicated international team has been able to create a pipeline of ADC product candidates in various stages of development to enter clinical phases to create better treatments for cancer patients in need of more selective drugs.
Corporate Firmographics
Entity classification and operating profile
- Industry
- General
- Company Type
- Privately Held
- Founded
- Undisclosed
- Employee Bracket
- 11-50
- Estimated Revenue Range
- Undisclosed
Geographic Coordinates
Headquarters address and regional territory
- Street Address
- Hochbergstrasse 60C Basel
- City
- Bad Kreuznach
- Region / State
- Rhineland-Palatinate
- Postal Code
- 4057
- Country
- Germany
Digital Presence & Footprint
Verified domains, socials, and directory profiles
Frequently Asked Questions
Verified business inquiries and firmographic telemetry for NBE-Therapeutics AG.